Trial Profile
A prospective study of roxadustat in reducing delayed graft function and acute rejection after renal transplantation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary)
- Indications Delayed graft function; Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 31 Jul 2020 New trial record